Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-132927
Filing Date
2020-12-07
Accepted
2020-12-07 17:25:31
Documents
44
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2037442d1_10q.htm 10-Q 200839
2 EXHIBIT 31.1 tm2037442d1_ex31-1.htm EX-31.1 12036
3 EXHIBIT 31.2 tm2037442d1_ex31-2.htm EX-31.2 12065
4 EXHIBIT 32.1 tm2037442d1_ex32-1.htm EX-32.1 5171
5 EXHIBIT 32.2 tm2037442d1_ex32-2.htm EX-32.2 5075
  Complete submission text file 0001104659-20-132927.txt   1622103

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eucr-20200930.xml EX-101.INS 141915
7 XBRL TAXONOMY EXTENSION SCHEMA eucr-20200930.xsd EX-101.SCH 35235
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eucr-20200930_cal.xml EX-101.CAL 10833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eucr-20200930_def.xml EX-101.DEF 99851
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eucr-20200930_lab.xml EX-101.LAB 203498
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eucr-20200930_pre.xml EX-101.PRE 172619
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8
Type: 10-Q | Act: 34 | File No.: 001-39650 | Film No.: 201373592
SIC: 6770 Blank Checks